american diabetes association 'history of pancreatitis' glp-1 receptor agonist history pancreatitis GLP-1 Agonists and Pancreatitis Risk: Reassessing an Old Concern with New Evidence Xia & He Publishing
Description
A retrospective analysis of combination therapy with GLP-1 receptor agonists and SGLT2 inhibitors versus SGLT2 inhibitor monotherapy in patients with MASLD
Some insurance companies include elevated waist circumference as a qualifying comorbidity for GLP-1 coverage
Tanaka M, Matsuo Y, Yamakage H, Masuda S, Terada Y, Muranaka K, Wada H, Hasegawa K, Shimatsu A, Satoh-Asahara N
Beyond primary care, the growth of digital and remote prescribing channels has broadened access to GLP-1 therapies significantly, reaching patients who may not easily access specialist weight management services through traditional routes
Injectable semaglutide can be taken at any time of day, with or without meals
They may be taking other medications that influence urinary health
